Researchers at the National University of Singapore, Yong Loo Lin School of Medicine, have discovered that the use of a common antibiotic, doxycycline, in combination with TB drug treatment, reduces the size of lung cavities and accelerates markers of lung recovery. This was done in a trial with 30 pulmonary tuberculosis patients.

Read More at

https://www.sciencedaily.com/releases/2021/06/210619160806.htm

At Washington, Scientists have found a compound that prevents and even reverses resistance to a widely used antibiotic for treating tuberculosis -- the most lethal infectious disease worldwide.

Read More at

https://health.economictimes.indiatimes.com/news/diagnostics/drug-resistant-tuberculosis-reversed-in-lab/69661931

Scientists, including those from Nanyang Technological University (NTU) in Singapore, discovered that the compound, known as epigallocatechin gallate (EGCG), can inhibit the growth of a tuberculosis-causing bacteria strain.

Read More at

https://health.economictimes.indiatimes.com/news/industry/green-tea-plant-compound-may-help-fight-tb-study/72871659

With WHO’s emphasis on the development of non-syringe vaccine delivery through the Global Vaccine Action Plan 2011-2020, mucosal vaccine delivery can be explored as a strategy for vaccination against TB.

Read More at

https://health.economictimes.indiatimes.com/news/industry/industry-academia-partnership-can-bring-about-new-tb-treatment-methods-prof-mala-menon/74781883

Global efforts are derailed by this pandemic to   tackle Tuberculosis. Following national lockdown the weekly and monthly number of TB case notifications fell by more than 50% between the end of March and late April.

Read more at: https://science.thewire.in/health/tuberculosis-who-annual-report-india-notifications-dropped-covid-19/